Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Multi-Hit TP53 Mutations in Myeloid Neoplasms: Prognostic Impact of Morphologic Subtype Designation and Variant Allele Frequency

Maymona Abdelmagid, Kaaren K. Reichard, Omer Karrar, Rong He, Patricia Greipp, Rhett Ketterling, Mithun V Shah, Devendra Hiwase, Attilio Orazi, Daniel A. Arber, Naseema Gangat, Ayalew Tefferi

Blood (2023) 142 (Supplement 1): 4214.

https://doi.org/10.1182/blood-2023-183010

Published: 2023

Journal Articles

TP53 Variant Allele Frequency and Therapy-Related Setting Independently Predict Survival in Myelodysplastic Syndromes with Del(5q)

Blood (2023) 142 (Supplement 1): 3234.

https://doi.org/10.1182/blood-2023-185023

Published: 2023

Journal Articles

Comparison of World Health Organization and International Consensus Classification Guidelines for Myeloid Neoplasms Harboring TP53 -Mutations Using an Independent International Cohort

Blood (2023) 142 (Supplement 1): 3243.

https://doi.org/10.1182/blood-2023-187860

Published: 2023

Journal Articles

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

Blood (2022) 140 (21): 2228–2247.

https://doi.org/10.1182/blood.2022015853

Published: 2022

Includes: Supplemental data

Journal Articles

Reappraisal of Mast Cell Leukemia Based on a Single Institution Review of 16 Cases: Role of Mast Cell Morphology in Determining Clinical Outcome

Animesh Pardanani, Ayalew Tefferi, Amritpal Singh, Aref Al-Kali, Mrinal M. Patnaik, William J. Hogan, Kebede Begna, Michelle A Elliott, Nandita Khera, Jeanne M. Palmer, Naseema Gangat, Attilio Orazi, Katalin Kelemen, Kaaren K. Reichard, Dong Chen

Blood (2022) 140 (Supplement 1): 6872–6873.

https://doi.org/10.1182/blood-2022-167720

Published: 2022

Journal Articles

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans-Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso-Ramos, Jorge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström-Lindberg, Gabriela S. Hobbs, Ronald Hoffman, Elias J. Jabbour, Jean-Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L.-C. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte Niemeyer, Olatoyosi M. Odenike, Seishi Ogawa, Alberto Orfao, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching-Hon Pui, Jerald P. Radich, Andreas Reiter, Maria Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt-Graeff, Akiko Shimamura, Jorge Sierra, Wendy A. Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei-Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi

Blood (2022) 140 (11): 1200–1228.

https://doi.org/10.1182/blood.2022015850

Published: 2022

Includes: Supplemental data

Journal Articles

Retrospective Study of Incidence and Survival for Patients with Hematologic Malignancies Residing at the U.S./Mexico Border

Alfonso Enrique Bencomo, PhD, Andres J Rubio, MS, Mayra Alejandra Gonzalez, BS, Idaly Maria Olivas, BS, Joshua Lara, BS, Kiran Ghimire, MD, Osvaldo Padilla, MD, Angelica Padilla, MD, Nawar Hakim, MD, Attilio Orazi, MD, Javier Corral, MD, Alexander Philipovskiy, MD PhD, Sumit Gaur, MBBS, Anna M. Eiring, PhD

Blood (2019) 134 (Supplement_1): 4782.

https://doi.org/10.1182/blood-2019-126150

Published: 2019

Journal Articles

Results from the Myeloproliferative Neoplasm Patient Care Survey: Patient Care Opportunities and Challenges

Zhenya Senyak, Ruben A. Mesa, MD FACP, Nicolaus Kroeger, MD, Koen Van Besien, MD PhD, Wael Saber, MD MS, Richard T. Silver, MD, Attilio Orazi, MD, Jeanne Palmer, MD, Claire N. Harrison, MD DM, FRCP, PRCPath, Srdan Verstovsek, MD PhD, Uday Popat, MD, Michelle J Woerhle, MPH, Ann Brazeau, Barbara Van Husen, Martin Prager, Chris Harper, Beatrice Larroque, Robyn Marie Scherber, MD MPH

Blood (2018) 132 (Supplement 1): 4289.

https://doi.org/10.1182/blood-2018-99-113910

Published: 2018

Journal Articles

Clinical, Immunophenotypic and Genomic Findings of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow Pathology Group

Olga K Weinberg, MD, Robert P. Hasserjian, MD, Ezra Baraban, MD, Chi Young Ok, MD, Julia T Geyer, MD, John KSS Philip, MD, Jason H. Kurzer, MD PhD, Heesun J. Rogers, MD PhD, Valentina Nardi, MD, Richard M. Stone, MD, Jacqueline S. Garcia, Eric D. Hsi, MD, Adam Bagg, MD, Sa A. Wang, MD, Attilio Orazi, MD, Daniel A. Arber, MD

Blood (2018) 132 (Supplement 1): 1491.

https://doi.org/10.1182/blood-2018-99-115198

Published: 2018

Journal Articles

Clinical Implications of TP53 Mutations and p53 Dysfunction in Patients with Myelodysplastic Syndrome (MDS). a Study from the Italian MDS Clinical Network

Blood (2017) 130 (Supplement 1): 2959.

https://doi.org/10.1182/blood.V130.Suppl_1.2959.2959

Published: 2017

Journal Articles

Eltrombopag (EPAG) Treatment Improved Platelet Counts in Patients with Persistent or Chronic Immune Thrombocytopenia during a 2-Year, Phase IV, Open-Label Study

Raymond SM Wong, MRCP,FRCP, Russell K Brynes, Attilio Orazi, Zeba Aziz, MD MBBS, Anait L. Melikyan, MD PhD, Abdulgabar Salama, Ozlem Ocak Arikan, Joan Maier, Tahir Shamsi, Professor of Haematology (FRCPath)

Blood (2017) 130 (Supplement 1): 3628.

https://doi.org/10.1182/blood.V130.Suppl_1.3628.3628

Published: 2017

Journal Articles

Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma

Blood (2016) 128 (26): 3083–3100.

https://doi.org/10.1182/blood-2016-05-715094

Published: 2016

Includes: Supplemental data

Journal Articles

Evaluation of Bone Marrowmmorphology in Addition to JAK2 Allele Burden Is Essential for Assessing Disease Status in Recombinant Interferon Alpha-Treated Polycythemia Vera Patients

Elizabeth Michelle Margolskee, MD MPH, Spencer Krichevsky, Attilio Orazi, MD, Richard T. Silver, MD

Blood (2016) 128 (22): 5471.

https://doi.org/10.1182/blood.V128.22.5471.5471

Published: 2016

Journal Articles

The Effect of Initial Molecular Profile on Response to Recombinant Interferon Alpha (rIFNα) Treatment in Early Myelofibrosis

Richard T. Silver, Ariella Barel, Elena Lascu, BA,MA, Ellen K. Ritchie, MD, Gail J. Roboz, MD, Paul Christos, Attilio Orazi, MD, Duane C Hassane, PhD, Wayne Tam, MD PhD, Nicholas C.P. Cross, PhD

Blood (2016) 128 (22): 944.

https://doi.org/10.1182/blood.V128.22.944.944

Published: 2016

Journal Articles

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Daniel A. Arber, Attilio Orazi, Robert Hasserjian, Jürgen Thiele, Michael J. Borowitz, Michelle M. Le Beau, Clara D. Bloomfield, Mario Cazzola, James W. Vardiman

Blood (2016) 127 (20): 2391–2405.

https://doi.org/10.1182/blood-2016-03-643544

Published: 2016

Includes: Supplemental data

Journal Articles

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

Blood (2015) 125 (12): 1857–1865.

https://doi.org/10.1182/blood-2014-10-607341

Published: 2015

Journal Articles

Akt Activation Confers an Inferior Survival in Patients with Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Blood (2014) 124 (21): 143.

https://doi.org/10.1182/blood.V124.21.143.143

Published: 2014

Journal Articles

NF-κB Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Blood (2014) 124 (21): 1620.

https://doi.org/10.1182/blood.V124.21.1620.1620

Published: 2014

Journal Articles

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

Mihai Merzianu, MD, Richard Cheney, MD, Adrienne Groman, MS, George Deeb, MD, Gregory Wilding, PhD, Claudiu Cotta, MD, Ramila Amre, MD, Manjula Balasubramanian, MD, Guilherme Brandao, MD, Russell K. Brynes, MD, Sindhu Cherian, MD, Elizabeth Courville, MD, David Czuchlewski, MD, Guang Fan, MD PhD, David Grier, MD, Daniela Hoehn, MD PhD, Robert E Hutchison, MD, Kedar V. Inamdar, MD PhD, Ridas Juskevicius, MD, Prabhjot Kaur, MD, John Lazarchick, MD, Michael R Lewis, MD, Rodney R. Miles, MD PhD, Jerome B. Myers, MD PhD, Michel Nasr, MD, Hina Naushad, MD, Horatiu Olteanu, MD PhD, Attilio Orazi, MD, Vishnu VB Reddy, MD, Valentin G Robu, MD, Gratian Salaru, MD, Julie Teruya-Feldstein, MD, Neerja Vajpayee, MD, Jeffrey Vos, MD, Ling Zhang, MD, Shanxing Zhang, MD PhD, Ashley V Sedelmeyer, MHA, Vivian Arguello, MD, Le Aye, DO, Sharon Barouk, MA, Elisa F Brega, MD PhD, Richie Carpenter, BS, James E. Coad, MD, Alana DiPonio, MT, Fernandez Garcia, MS, MD, John Grantham, BS, Sinisa Ivelja, MD, Robert McKenna, MD, Kieran Sultan, MD, Matthew B Thomsen, MPH, Jie Xu, MD PhD, LoAnn Peterson, MD, Vishala T. Neppalli, MD

Blood (2014) 124 (21): 1316.

https://doi.org/10.1182/blood.V124.21.1316.1316

Published: 2014

Journal Articles

MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis

Blood (2014) 124 (7): 1183–1191.

https://doi.org/10.1182/blood-2014-04-572545

Published: 2014

NARROW

Multi-Hit TP53 Mutations in Myeloid Neoplasms: Prognostic Impact of Morphologic Subtype Designation and Variant Allele Frequency

TP53 Variant Allele Frequency and Therapy-Related Setting Independently Predict Survival in Myelodysplastic Syndromes with Del(5q)

Comparison of World Health Organization and International Consensus Classification Guidelines for Myeloid Neoplasms Harboring TP53 -Mutations Using an Independent International Cohort

Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

Reappraisal of Mast Cell Leukemia Based on a Single Institution Review of 16 Cases: Role of Mast Cell Morphology in Determining Clinical Outcome

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Retrospective Study of Incidence and Survival for Patients with Hematologic Malignancies Residing at the U.S./Mexico Border

Results from the Myeloproliferative Neoplasm Patient Care Survey: Patient Care Opportunities and Challenges

Clinical, Immunophenotypic and Genomic Findings of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow Pathology Group

Clinical Implications of TP53 Mutations and p53 Dysfunction in Patients with Myelodysplastic Syndrome (MDS). a Study from the Italian MDS Clinical Network

Eltrombopag (EPAG) Treatment Improved Platelet Counts in Patients with Persistent or Chronic Immune Thrombocytopenia during a 2-Year, Phase IV, Open-Label Study

Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma

Evaluation of Bone Marrowmmorphology in Addition to JAK2 Allele Burden Is Essential for Assessing Disease Status in Recombinant Interferon Alpha-Treated Polycythemia Vera Patients

The Effect of Initial Molecular Profile on Response to Recombinant Interferon Alpha (rIFNα) Treatment in Early Myelofibrosis

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

Akt Activation Confers an Inferior Survival in Patients with Activated B-Cell Subtype of Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

NF-κB Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program

Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study

MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only